Health and Medicine

The 8th Microbiome Movement Drug Development Summit returns in 2023 as North America's definitive microbiome drug development event - and it's back bigger and better than ever! The microbiome-based therapeutic market is rapidly evolving, and it's more important than ever to showcase the efficacy of microbial-based approaches beyond C. difficile. Discover how drug developers are advancing their understanding of the role of the microbiome in disease and harnessing functionally relevant microbes for live biotherapeutic approaches. Join us, as we provide in-depth insights into the interactions between the microbiome and metabolic pathways, host-microbe relationships in novel preclinical models, and the application…

The Clinical Decision Making in Emergency Medicine conference includes access to over 20 hours of engaging lectures from experts around the country. It provides participants with the most recent, evidence-based information on leading topics in emergency medicine. Presented by the nation's experts, the format for the sessions is case-based, with questions that highlight the main teaching points of the session, followed by a discussion of the main diagnostic and management issues related to the case, and ending with a focused discussion of the case's outcome. Who should attend this symposium? The conference is designed for Medical professionals working in ambulatory…

We are extremely gratified to declare our upcoming fortuitous neurology conference, 8th World Congress on Neurology and Therapeutics Conference, held during June 29-July 01, 2023 in London, UK. Our propitious neurology congress is tailored around the theme “Perceive the Innovative Neurology and Therapeutic Techniques”. This conference is intended to bring forth enthralling concepts that will drive the field of neurology to the next standards.

Newer and more complex molecules often complicate existing downstream processes. New, innovative technologies are necessary to ensure safe, efficient, and effective capture and purification of emerging modalities. In this interactive virtual event, our experts share their personal experiences and insight to help anticipate challenges and chose appropriate technologies to support your downstream strategies. Topics include advances in downstream purification processes new therapeutic modalities, vector increased, downstream processing challenges, and more.

The International Council of Nurses and the Canadian Nurses Association are delighted to invite you to attend the ICN Congress, 1-5 July 2023 in Montreal, Canada! With the theme “Nurses together: a force for global health”, the ICN 2023 Congress will bring together the powerful force of the 28 million nurses worldwide! For four days, we will unite to learn, share and network in order to build a better future for the nursing workforce and our healthcare systems! As the world’s largest international nursing event, the ICN Congress has proved itself as the global platform to gather and empower the…

We invite all participants worldwide to attend the“10th International Conference on Gynecology and Obstetrics” scheduled on July 03-04, 2023 at London, UK. The conference is going to be held on the theme “New innovations and Advancements in Gynecology and Obstetrics". The 10th International Conference on Gynecology and Obstetrics brings together a one-of-a-kind and global blend of large and medium pharmaceutical, biotech, and analytic organisations, colleges, and clinical research establishments, making the gathering an ideal stage for sharing involvement, cultivating cross-industry and scholarly collaboration, and assessing developing innovations around the world. We hope to provide an ideal platform for Researchers, Scholars,…

Lectures and cases will cover evidence-based practice techniques and protocols for improved diagnostic accuracy in multiple applications.At the conclusion of this activity, participants should be able to: *Describe the availability and use of decision-support tools for radiologists, to facilitate making more accurate and clinically useful diagnoses. *Use contemporary imaging techniques and protocols to accurately diagnose airway disease, lung infection, and mediastinal masses. *Describe thoracic radiologic procedures for clinical cancer management. *Outline CT protocols and techniques for improved clinical diagnosis of diseases of the cardiovascular system. *Integrate information presented in this course into efforts to improve the imaging skills of the…

The landscape of microbiome drug development is constantly evolving. The road to market is incredibly complex and it's vital to find the right strategic partners to bring products to patients. Microbiome Connect: Europe is the sector's premier strategic event, enabling you to discover new innovative technologies and foster connections that will ensure your company's clinical and commercial success. Bringing together the whole microbiome therapeutics ecosystem - from investors and large pharmaceutical companies, through to the most pioneering biotechs, academic institutions and solution providers - it delivers the business-critical information you need to make strategic decisions for your organisation through in-depth…

It is our great pleasure to extend a warm welcome to The 2nd European Congress on Legal and Regulations in Cannabis (LR-Cannabis) which will take place 6-7 July in Brussels, Belgium. The aim of this Congress is to explore the intricacies of medical Cannabis regulations under the law, including valuable insights and practical knowledge from industry leaders, with a strong focus on regulation. Since the previous Legal and Regulations in Cannabis conference held in Vienna, Austria in February 2020, the Cannabis industry, and the field of legal and regulations in Cannabis, has experienced significant shifts. Several countries have made regulatory…

Scripps MD Anderson Cancer Center's 2023 Oncology Update is a one-day conference designed to offer clinicians and advanced practice providers a comprehensive overview of the most recent advances in the treatment of various oncologic malignancies. During this comprehensive educational course, clinical experts in the fields of hematology and oncology will provide an overview of key findings from practice changing studies and the latest clinical data. Esteemed faculty will review exciting and important abstracts and discuss their relevance to the clinical oncology practice. Prices: Physicians (MD, DO, MBBS): USD 150.00, Non-physicians: USD 125.00 Time: 07:00 to 15:00

Call for Paper Conference is a premier platform for the presentation of novel and creative research results in the fields of theoretical, and applied Medical and medicine research, Health Sciences and Public Health research & practice. The conference will bring together leading researchers, social workers and scientists , students in the domain of scientific interest from around the world.

Call for Paper Conference is a premier platform for the presentation of novel and creative research results in the fields of theoretical, and applied Medical and medicine research, Health Sciences and Public Health research & practice. The conference will bring together leading researchers, social workers and scientists , students in the domain of scientific interest from around the world.

The field of acute cardiac care is evolving promptly, as the population ages and the patients are becoming more complex and challenging, however our medical capabilities have improved accordingly. We are happy to invite you to the 13th International Conference on Acute Cardiac Care 2023. Come and be a part of the worldwide community at this exciting era, share late-breaking science and enrich your skills and knowledge at these critical cardiac topics. This conference, held under the auspices of the ESC Association for Acute Cardiovascular Care (ACVC) and Israeli Heart Association (IHS), has become one of the leading scientific events…

Lectures and cases will cover evidence-based practice techniques and protocols for improved diagnostic accuracy in multiple applications. At the conclusion of this activity, participants should be able to: *Develop a differential diagnosis that relates to the pertinent imaging and clinically relevant findings for each of the cases covered in this course. *Describe the imaging anatomy and protocols that are necessary to arrive at a diagnosis of liver diseases. *Optimize imaging methods to reduce the number of false-positive mammography interpretations. *Assess the current status and future applications of advanced breast imaging technologies. *Explain the performance and processing of MRI and CT…

Returning to Boston for 2023, the 2nd In Vivo Engineering of Therapeutic Cells Summit is the only industry focused meeting place future innovations in the cell and gene space front and centre - dedicating time to explore the blockbuster potential of in vivo cell engineering with a key focus on optimizing delivery, targeting and specificity. Get caught up to speed on this dynamic industry with expertise shared from the likes of Capstan Therapeutics, Interius Biotherapeutics, Vector Biopharma and many others as the titans of industry unite to showcase the latest delivery technologies that are set to transform the cell and…

The 4th RNA Editing Summit returns as the first and only industry-dedicated forum solely focused on the research and therapeutic potential of RNA editing. Our 2023 event will welcome first disclosures of exciting data with important learnings being communicated so the field can advance toward the clinic. Expect exclusive data from KOLs on the most recent developments in ADAR, APOBEC, CRISPR-Cas13, Cas7-11, and exon editing. Join 80+ thought leaders from the likes of Wave Life Sciences, ProQR, Shape Therapeutics and Korro Bio to stay ahead of the curve and tap into the therapeutic potential of RNA editing and accelerate clinical…

Join 100+ of your digital health and CNS clinical development peers to address the standardization and regulatory acceptance of digital tools and data analysis as endpoints in complex neurological indications, discover novel innovations for objective, sensitive, and non-invasive neurological measures, and ensure internal confidence and scalability with emerging digital technologies. Uniting Digital Health Biopharma with CNS Clinical Drug Developers to: 1. Address the Standardization and Regulatory Acceptance of Digital Tools and Data Analysis as Endpoints in Complex Neurological Indications 2. Discover Novel Innovations for Objective, Sensitive, and Non-Invasive Neurological Measures 3. Ensure Confidence and Scalability with Emerging Digital Technologies URL:…

With more than 300 trials in preclinical and clinical development actively using AAV as their vector of choice, the priority for any company working in this space is to ensure that each and every one of those therapies is the safest version it can be. In this context, the 2nd Annual Optimizing AAV Safety Summit is returning in 2023, bringing together genetic therapy leaders across non-clinical development, clinical development, toxicology, biodistribution, and immunology who are all working to optimize the safety of their AAV-based drug products in their day-to-day. By addressing key topics including how to extract the most relevant…

This year's summit places heavy weighting on the technical implications for the production of novel foods: - Strain development and synthetic biology technologies - Scale-up planning and execution case studies - Ideal fermentation design panel discussions: liquid vs solid-state approaches - Downstream purification techniques: yield maximisation and by-product minimisation In addition to these in-depth example-based sessions, our focus day is set to explore personal commercial and regulatory journeys, from companies such as Better Dairy, Unilever, and ENOUGH. This event is the ultimate platform for precision and biomass fermentation companies and end-to-end product users to explore the novel foods industry from…

Over the last 12 months, we have seen many combination therapies enter Phase I and II trials with both successes and challenges, particularly in solid tumors. The FDA Modernization Act 2.0 passing has also steered biopharma away from animal models, empowering the preclinical and translational tumor models' space to continue innovating and decrease the translational gap into the clinic. At the 11th Annual Tumor Models Boston Summit, you will gain practical insights into the latest updates through 25+ case studies across 2 dedicated tracks. Join us to learn from and meet pioneers in preclinical and translational targeted, combination oncology to…